These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 14125621)

  • 1. [EFFECTS OF HYDROCHLOROTHIAZIDE ASSOCIATED WITH ALDOSTERONE IN THE THERAPY OF NEPHROTIC EDEMA. I. CLINICAL RESULTS AND STUDY OF WATER AND SALT METABOLISM IN 3 CASES].
    ANIBALDI A; BOSCHERINI B; PATANE E; PEDULLA T
    Prog Med (Napoli); 1963 Sep; 19():521-9. PubMed ID: 14125621
    [No Abstract]   [Full Text] [Related]  

  • 2. [EFFECTS OF HYDROCHLOROTHIAZIDE ASSOCIATED WITH ALDOSTERONE ANTAGONISTS IN THE THERAPY OF INFANTILE NEPHROTIC EDEMA. II. STUDY OF OSMOLAR CLEARANCES AND FREE WATER].
    ANIBALDI A; BOSCHERINI B; PAIELLA R
    Prog Med (Napoli); 1963 Sep; 19():548-52. PubMed ID: 14122942
    [No Abstract]   [Full Text] [Related]  

  • 3. [ALDOSTERONE AND SPIROLACTONES IN THE CLINICAL TREATMENT OF INTERNAL DISEASES (REVIEW OF THE LITERATURE AND ANALYSIS OF PERSONAL CASES)].
    POLIANTSEVA LR; ERMOLENKO VM
    Sov Med; 1963 Dec; 27():42-51. PubMed ID: 14150357
    [No Abstract]   [Full Text] [Related]  

  • 4. [STUDIES OF THE PATHOGENESIS AND THERAPY OF INFANTILE NEPHROTIC EDEMA. OBSERVATIONS ON 8 CASES TREATED WITH COMBINED HYDROCHLOROTHIAZIDE AND ALDOSTERONE ANTAGONISTS].
    ANIBALDI A; BOSCHERINI B
    Arch Ital Pediatr Pueric; 1963; 23():112-31. PubMed ID: 14134457
    [No Abstract]   [Full Text] [Related]  

  • 5. [CONTRIBUTION TO THE PROBLEM OF IDIOPATHIC EDEMA].
    BOEHM P; FRANKEN FH; IRMSCHER K
    Klin Wochenschr; 1963 Dec; 41():1155-61. PubMed ID: 14114041
    [No Abstract]   [Full Text] [Related]  

  • 6. [THE MODES OF RENAL ACTION OF ALDOSTERONE INHIBITORS. DEDUCTIONS CONCERNING THE POINTS OF ATTACK OF ALDOSTERONE AT THE LEVEL OF THE KIDNEY].
    ROMANI JD; BERNHEIM R; GOOSENS F
    Ann Endocrinol (Paris); 1963; 24():588-97. PubMed ID: 14051313
    [No Abstract]   [Full Text] [Related]  

  • 7. [Apropos of a pure lipoid nephrosis in a child treated with spirolactone].
    JEUNE M; SALLE B; PUGEAUT R; BONNEFOY S
    Lyon Med; 1961 May; 93():1179-83. PubMed ID: 13790026
    [No Abstract]   [Full Text] [Related]  

  • 8. [SECONDARY HYPERALDOSTERONISM. PHYSIOPATHOLOGIC, CLINICAL AND THERAPEUTIC CONSIDERATIONS].
    DEMARTINIS C; FONZO D
    Clin Ter; 1963 Oct; 27():51-72. PubMed ID: 14097444
    [No Abstract]   [Full Text] [Related]  

  • 9. [ON THE DIURETIC EFFECT OF THE ADRENOSTATIC DRUG METHOPYRAPONE].
    HIERHOLZER K
    Dtsch Med Wochenschr; 1964 Jun; 89():1124-7. PubMed ID: 14152369
    [No Abstract]   [Full Text] [Related]  

  • 10. Influence of spironolactone in modifying the renal electrolyte effects of hydrochlorothiazide in laboratory animals.
    KAGAWA CM; DRILL VA
    Arch Int Pharmacodyn Ther; 1962 Apr; 136():283-90. PubMed ID: 14453072
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of spironolactone and hydrochlorothiazide in treatment of oedema.
    FARRELLY RO; HOWIE RN; NORTH JD
    Br Med J; 1960 Jul; 2(5195):339-43. PubMed ID: 13821638
    [No Abstract]   [Full Text] [Related]  

  • 12. CIRRHOSIS--FLUID RETENTION AND ASCITES.
    VOLWILER W
    Mod Treat; 1964 Mar; 1():451-61. PubMed ID: 14159599
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of adrenocorticotrophic hormone on salt and water excretion in children with the nephrotic syndrome.
    RILEY CM
    AMA Am J Dis Child; 1950 Sep; 80(3):520-1. PubMed ID: 14770468
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of various nephrotic edemas with the combination of chlorothiazide and spirolactone].
    MALLET R; BOUCHARD R; PRIEUR F; GUEDON J
    Arch Fr Pediatr; 1961 Apr; 18():504-11. PubMed ID: 14468962
    [No Abstract]   [Full Text] [Related]  

  • 15. Significance of aldosterone antagonism in the treatment of edema and ascites.
    GANTT CL; ECKLUND RE
    Am J Med; 1962 Oct; 33():490-500. PubMed ID: 13946423
    [No Abstract]   [Full Text] [Related]  

  • 16. [THE INTRODUCTION OF ALDOSTERONE ANTAGONISTS IN THERAPY].
    ROMANI JD
    Cah Coll Med Hop Paris; 1964 Jun; 5():517-22. PubMed ID: 14174282
    [No Abstract]   [Full Text] [Related]  

  • 17. [On the problem of clinical and electrolyte-chemical features in the course of corticosteroid therapy of nephrosis].
    BECKMANN R; HASTREITER AR
    Monatsschr Kinderheilkd (1902); 1960 May; 108():265-8. PubMed ID: 13798167
    [No Abstract]   [Full Text] [Related]  

  • 18. [PATHOPHYSIOLOGY AND CLINICAL ASPECTS OF SECONDARY ALDOSTERONISM AND ITS TREATMENT].
    HOFFMEISTER W
    Folia Clin Int (Barc); 1964 Mar; 14():124-44. PubMed ID: 14153959
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of SC 9420, mercurial diuretic and hydrochlorothiazide on electrolyte excretion in liver cirrhosis].
    VELASCO M; KATZ R; KATZ E; GARCIA H; GAZMURI R
    Rev Med Chil; 1959 Dec; 87():946-51. PubMed ID: 13841591
    [No Abstract]   [Full Text] [Related]  

  • 20. ALDOSTERONE ANTAGONISTS IN DIURETIC THERAPY: THEIR EFFECT ON THE REFRACTORY PHASE.
    SELLER RH; SWARTZ CD; RAMIREZ-MUXO O; BREST AH; MOYER JH
    Arch Intern Med; 1964 Mar; 113():350-5. PubMed ID: 14096385
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.